Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma

Published:2018-02-20 Issue:4 Volume:67 Page:1360-1377
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Shen Qingyu¹²,Eun Jung Woo¹²,Lee Kyungbun³,Kim Hyung Seok¹²,Yang Hee Doo¹²,Kim Sang Yean¹²,Lee Eun Kyung⁴,Kim Taemook⁵,Kang Keunsoo⁵,Kim Seongchan⁶,Min Dal-Hee⁶,Oh Soon-Nam⁷,Lee Young-Joon⁷,Moon Hyuk⁸,Ro Simon Weonsang⁸,Park Won Sang¹,Lee Jung Young¹,Nam Suk Woo¹²⁹

Affiliation:

1. Department of Pathology, College of Medicine; The Catholic University of Korea; Seoul Republic of Korea

2. Functional RNomics Research Center; The Catholic University of Korea; Seoul Republic of Korea

3. Department of Pathology, College of Medicine; Seoul National University; Seoul Republic of Korea

4. Department of Biochemistry, College of Medicine; The Catholic University of Korea; Seoul Republic of Korea

5. Department of Microbiology, College of Natural Sciences; Dankook University; Cheonan Republic of Korea

6. Center for RNA Research, Institute for Basic Science (IBS), Department of Chemistry; Seoul National University; Seoul Republic of Korea

7. Department of Radiology, College of Medicine; The Catholic University of Korea; Seoul Republic of Korea

8. Institute of Gastroenterology; Yonsei University College of Medicine; Seoul South Korea

9. Cancer Evolution Research Center; The Catholic University of Korea; Seoul Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Hepatology

Reference21 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma;Villanueva;Gastroenterology,2011

3. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma;Takayama;Lancet,1990

4. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma;Chuma;Hepatology,2003

5. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma;Sakamoto;Hum Pathol,1991

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer;Aging;2024-07-26

2. Establishment of diagnostic model and identification of diagnostic markers between liver cancer and cirrhosis based on multi‐chip and machine learning;Clinical and Experimental Pharmacology and Physiology;2024-07-04

3. Splicing Factor 3b Subunit 4 (SF3B4) Promotes Proliferation of Gastric Cancer through Regulation of VDAC1;2024-06-27

4. Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome;Hepatology International;2024-06-19

5. The Many Roads from Alternative Splicing to Cancer: Molecular Mechanisms Involving Driver Genes;Cancers;2024-06-01